Immunoreceptor tyrosine-based activation motifs (ITAMs) are involved in the transduction of signals necessary for activation, differentiation, and survival in hematopoietic cells. Several viruses have been shown to encode ITAM-containing transmembrane proteins. Although expression of these viral proteins has in some cases been shown to transform nonhematopoietic cells, a causal role for a functional ITAM in this process has not been elucidated. To examine the potential transforming properties of ITAM-containing proteins, a recombinant protein consisting of ITAM-containing cytoplasmic regions of the B-cell antigen receptor was expressed in immortalized murine mammary epithelial and fibroblast cells. Mammary epithelial cells expressing this construct exhibited depolarized morphology in three-dimensional cultures. This transformed phenotype was characterized by a loss of anchorage dependence and hallmarks of epithelial to mesenchymal transition. Fibroblasts expressing this ITAM construct also lost contact inhibition and anchorage dependence. The transformed phenotype seen in both cell types was abrogated upon tyrosine to phenylalanine substitutions of the ITAMs. Inhibition of Syk tyrosine kinase, which associates with the ITAM, also prevented cell transformation. Our results indicate that expression of a nonviral ITAM-containing protein is sufficient for cell transformation. Despite lacking intrinsic enzymatic activity, ITAM-containing proteins can function as potent oncoproteins by scaffolding downstream mediators.
Introduction
Activation of hematopoietic lineage immune system cells occurs following ligand-induced aggregation of receptors that contain immunoreceptor tyrosine-based activation motifs (ITAMs) responsible for the initiation of signal transduction events. Some of the most common ITAM-containing proteins include Iga (CD79a) and Igb (CD79b) of the B-cell receptor (BCR), the CD3 complex of the T-cell receptor, Fc receptor components (including the b and g chains of FceRI and z chain of FcgRIII), and the DAP12 protein of various activating NK receptors (Cannons and Schwartzberg, 2004; Harder and Engelhardt, 2004; Mina-Osorio and Ortega, 2004; Vivier et al., 2004) . These and other ITAM-associated receptor complexes generate signals involved in survival, activation, differentiation, and selection events by activating signal transduction pathways.
ITAMs are highly conserved motifs with the canonical sequence D/EX 0-2 YXXL/IX 6-8 YXXL/I (Reth, 1989) . Signal transduction by these motifs is initiated by Srcfamily protein tyrosine kinases (SPTKs) that phosphorylate the tyrosines within the ITAM. This phosphorylation leads to Src-homology 2 (SH2)-mediated docking and activation of Syk family kinases and recruitment of other adaptor molecules. The ensuing cascade of tyrosine phosphorylation initiated by these kinases culminates in the activation of several effector pathways, including PLCg/PKC/calcium mobilization, PI3K/Akt, Ras/MAPK, and NFkB (reviewed by Niiro and Clark, 2002) . Although signal transduction is traditionally thought of as being initiated upon ligand binding, there is evidence that ITAMs can also signal in a ligand-independent manner, termed tonic signaling (Bannish et al., 2001; Roose et al., 2003) . Tonic ITAM signaling is postulated to be held in check by negative coreceptors that contain immunoreceptor tyrosinebased inhibitory motifs (ITIMs) (Monroe, 2006) . These ITIM-containing coreceptors inducibly recruit cytoplasmic protein tyrosine phosphatases (PTPs), such as SHP-1, to attenuate nonspecific signaling. In their absence, uninhibited tonic signaling leads to lymphocyte hyperproliferative disorders (O'Keefe et al., 1996; Sato et al., 1996; Nitschke et al., 1997) .
ITAM-dependent receptors are predominantly restricted to hematopoietic cells. However, since their identification, it has been noted that a number of oncogenic viruses encode transmembrane ITAMcontaining proteins. These proteins include EpsteinBarr virus (EBV) LMP2A, murine mammary tumor virus (MMTV) Env, and Kaposi's sarcoma-associated herpesvirus (KSHV) K1 (Caldwell et al., 1998; Lee et al., 1998a; Katz et al., 2005) . Studies of signaling by LMP2A (Longnecker et al., 1991; Caldwell et al., 1998; Swart et al., 2000) and K1 (Lee et al., 1998a; Lagunoff et al., 1999) in B cells suggests that these ITAMs are capable of signaling in a manner similar to traditional cellular ITAMs. Additionally, nonhematopoietic cells expressing K1 and LMP2A are susceptible to transformation and in vivo tumor development (Lee et al., 1998b; Scholle et al., 2000; Prakash et al., 2002) . However, a causal role for a functional ITAM in the transformation of nonhematopoietic cells has not been elucidated.
We recently identified an ITAM associated with the Env protein of MMTV and established the ability of Env to transform NMuMG murine mammary epithelial cells (MECs) in three-dimensional (3D) Matrigel cultures by an ITAM/Syk-dependent pathway (Katz et al., 2005) . Specifically, we showed that NMuMG cells expressing the viral ITAM-containing protein MMTV Env exhibited several hallmarks of transformation, including depolarized 3D morphology, sensitivity to apoptosis induced by TRAIL or TNFa, and downregulation of E-cadherin and Keratin-18 (Katz et al., 2005) . The ability of Env to transform mammary epithelial cells was dependent on an intact ITAM. These results identified the Env protein as a potent transforming agent and indicated that Env expression may play a role in MMTV-induced mammary gland tumors via an ITAM-dependent mechanism.
Not tested in our previous studies was whether the ITAM per se is sufficient for Env-induced transformation or whether this effect reflected a unique property of virus-encoded ITAM proteins, with potential contributions by other attributes of MMTV Env. In addition, whether this transformation-inducing effect of Env was specific to epithelial tissues or indicative of a more general oncogenic potential for ITAM-containing proteins in nonhematopoietic cells was not determined. In this report, we have directly addressed these issues by examining the ability of normal cellular ITAM-containing proteins to trigger transformation-associated processes in both murine MECs and fibroblasts. We show that expression of a membrane-targeted fusion protein comprised of the ITAM-containing cytoplasmic domains of BCR Iga and Igb (Bannish et al., 2001) transforms MECs in an ITAM-dependent manner. This result was demonstrated by a loss of anchorage dependence and a disruption of the polarized acinar structure that forms in 3D recombinant basement membrane cultures. This Iga/Igb protein also resulted in the loss of E-cadherin, induction of vimentin, and sensitivity to TRAIL and TNFa. In addition to transforming MECs, expression of this nonviral ITAM-containing protein also resulted in the transformation of fibroblasts, indicated by a loss of both anchorage dependence and contact inhibition.
Collectively, these results suggest that expression of ITAM-containing proteins is sufficient for transformation of nonhematopoietic cells and thereby identifies them as oncoproteins.
Results
MAHB: a nonviral, membrane-bound, ITAM-containing protein To determine if transformation is a general consequence of expressing ITAM-containing proteins in nonhematopoietic tissues, we used a fusion protein termed MAHB. Instead of encoding a viral ITAM motif, MAHB encodes the cellular ITAMs of Iga and Igb, which are normally expressed as a heterodimer in B cells and are nontransforming in this cellular context. A general feature of cellular ITAM-based receptors is their existence as multiprotein complexes at the cell surface, whose components cannot be transported individually to the cell surface (Weiss and Stobo, 1984; Hombach et al., 1990) . To circumvent the need to express the entire BCR complex, we directly targeted MAHB to the plasma membrane using the myristoylation/palmitoylation sequence of Lck (Bannish et al., 2001) (Figure 1a ). In addition, we generated a signaling-deficient variant of this protein, ITAMmutant, in which the ITAM tyrosines were substituted with phenylalanine (equivalent to Y182F, Y193F in Iga and Y195F, Y206F in Igb). This variant was used to confirm that effects observed following MAHB expression was ITAM dependent. Both the MAHB and ITAMmutant proteins were cloned into the MIGR1 retroviral vector that expresses a bicistronic mRNA encoding either MAHB or ITAMmutant and GFP (Pui et al., 1999) . The retroviral transduction efficiency for each construct was about 50%, as indicated by GFP expression (data not shown). Stable cell lines were then generated by sorting cells expressing high levels of GFP, which comprised approximately 10-15% of the transduced population. Based upon GFP or protein expression, we routinely observed that MAHB was expressed at lower levels than ITAMmutant in both cell types used (Figure 1b and c and data not shown). The reason for this is not known, but should not affect interpretations of our results as the negative controls (ITAMmutant and MIGR) are the higher expressors. Finally, MAHB and the ITAMmutant protein expression and membrane localization were confirmed by immunostaining for the HA-tagged proteins, as shown in Figure 1c . Monitoring growth rates and survival of NMuMG cells in 2D cultures failed to reveal any differences between cell populations expressing any of these chimeric proteins (data not shown).
Plasma membrane targeted expression of Iga/Igb cytoplasmic domains triggers ITAM-dependent transformation of mammary epithelial cells To determine if expression of MAHB was able to transform MECs in vitro, the formation of 3D acinar structures was monitored. When placed on a recombinant basement membrane (Matrigel) with the proteins necessary to provide attachment and survival factors, MECs develop into growth-arrested, organized acinar structures. These structures faithfully recapitulate, in vitro, the acinar architecture of mammary epithelium in vivo, including apical-basal polarization of luminal epithelial cells surrounding a hollow lumen (reviewed in Jacks and Weinberg, 2002 ). This experimental model has proven useful for dissecting the molecular processes associated with oncogene-induced transformation of MECs, including that induced by activated ErbB2 (Muthuswamy et al., 2001 ) and altered integrin expression (Weaver et al., 1997; Zahir et al., 2003) .
Oncogenic disruption of acini is evaluated by assessment of the enhanced frequency of enlarged structures and bright field images illustrating alterations in overall morphology. Since the disruption of acini seen in 3D cultures is quite diverse, we developed a more unbiased and quantitative method to score the phenotype of acini based on their morphological characteristics. On a scale of zero (normal) to five (most abnormal), acini were evaluated based on their shape, size, presence of a lumen, structural integrity, and cellular morphology. For individual structures, one point is given for each of the following abnormalities: being nonspherical, enlarged (diameter over 50 mm), having a malformed (or multiple) lumen(s), branching from the 3D structure, and having abnormal cellular morphology. Examples of acini and their respective scores are shown in Figure 2a .
The phenotypes of acini expressing MAHB, ITAMmutant, or the empty vector (MIGR) were scored using the scheme described above. As shown in Figure 2b , NMuMG cells transduced with MIGR formed intact polarized acinar structures with a hollow lumen similar to wild-type cells. With respect to their average score, the acinar structure of cells expressing MIGR was very similar to wild-type NMuMG cells (data not shown). MAHB-expressing NMuMG cells developed depolarized acini (Figure 2b) , similar to what was seen upon expression of the Env protein of MMTV (Katz et al., 2005) . The population of MAHB-expressing acini as a whole were significantly (Po0.0001) more abnormal than those expressing GFP alone ( Figure 2b ). Despite some variation between experiments, the MAHBexpressing NMuMG acini on average consistently scored higher than those expressing GFP alone or the ITAMmutant. Additionally, when compared to MIGRand ITAMmutant-transduced NMuMG cells, MAHBexpressing cells formed fewer normal structures, and each of the individual morphological abnormalities examined occurred with a higher frequency (Figure 2c ). No correlation was found between low and high amounts of MAHB within these sorted populations (as determined by GFP fluorescence) and the degree of acinar depolarization (data not shown). Acinar structures formed by ITAMmutant-expressing NMuMG cells were normal, indicating that the depolarization induced by MAHB expression was ITAM dependent (Figure 2b ). This failure of the ITAMmutant to induce depolarization of 3D acini is not due to low protein expression, as the variant was expressed at higher levels than MAHB (Figure 1c and data not shown).
We also examined the ability of anchorage-dependent NMuMG lines to form colonies in soft agar-methocellulose cultures. As depicted in Figure 3 , inefficient colony formation was observed in MIGR-expressing cells. However, expression of MAHB in these cells resulted in more colonies (1586 compared to 140) that were significantly larger (97 mm compared to 86 mm, Po0.0001) (Figure 3 ). In regards to both number and size, colony formation was reduced to nearly background (MIGR) in the ITAMmutant-expressing NMuMG cells (Figure 3 ). These results indicate that the loss of anchorage dependence driven by MAHB was ITAM dependent.
ITAM expression induces an EMT phenotype in mammary epithelial cells
Previous studies established that MMTV Env expression in NMuMG cells grown in 3D culture triggered phenotypic changes consistent with epithelial to mesenchymal transition (EMT). This process is believed to predict aggressive metastatic transformation in vivo (Thiery, 2002) . The changes induced by Env included a loss of two epithelial markers, E-cadherin and keratin 18 (Katz et al., 2005) . Consistent with induction of an ITAM-mediated EMT, we observed a loss of the epithelial marker E-cadherin only in NMuMG cells expressing MAHB (Figure 4a ). MIGR-and ITAMmutant-expressing NMuMG cells expressed similar amounts of E-cadherin (Figure 4a ). In addition, NMuMG cells transduced with MAHB gained expression of the mesenchymal marker vimentin, whereas MIGR-and ITAMmutant-expressing cells did not (Figure 4b ). This loss of E-cadherin and acquisition of vimentin by NMuMG cells expressing MAHB suggests that these cells are undergoing an EMT.
Sensitivity of depolarized MAHB-expressing acini to TRAIL and TNFa Further characterization of the transformed phenotype seen with NMuMG cells expressing MAHB in 3D cultures led us to examine their sensitivity to apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) and TNFa in 3D cultures. In the presence of exogenous proapoptotic stimuli, normal acini are resistant to apoptosis as a consequence of basement membrane-driven polarization (Weaver et al., 2002) . However, acini that have become depolarized following oncogene expression become sensitive to apoptosis induction due to disrupted integrin signaling (Weaver et al., 2002) . Following treatment with TRAIL and TNFa, only MAHB-expressing acini showed evidence of caspase-3-dependent apoptosis ( Figure 5 ). MIGR-and ITAMmutant-expressing acini were not sensitive to apoptosis ( Figure 5 and data not shown). The sensitivity of MAHB-expressing NMuMGs to these proapoptotic agents is similar to that reported for MMTV Env and other mammary oncoproteins (Weaver et al., 1997; Katz et al., 2005) . Taken together, the depolarized acinar structures formed in 3D Matrigel cultures, ability to form colonies in soft agar, sensitivity to apoptotic agents, and marker expression exhibited by MAHB-expressing cells indicate that expression of a nonviral ITAM-containing protein is capable of transforming murine MECs. Further, the hallmarks of transformation triggered by MMTV Env were also evident in NMuMG cells expressing the cellular ITAM-containing proteins.
Src and Syk tyrosine kinases contribute to ITAM-induced acinar depolarization
In hematopoietic cells, ITAM signaling requires the activity of both Src and Syk family kinases. SPTKs are involved in initial ITAM phosphorylation. Phosphorylation of ITAM tyrosines generates docking sites for SH2 domain-dependent recruitment and activation of Syk. Syk activation propagates this ITAM-initiated signaling cascade by phosphorylating downstream adaptor proteins and enzymes (Niiro and Clark, 2002) . The phosphorylation status of the chimeric proteins was examined in 2D cultures by anti-phosphotyrosine and anti-HA immunoblotting. In ITAMmutant-expressing NMuMG cells, two bands with an approximate molecular weight of 25 kDa were detected by anti-HA immunoblotting, neither of which showed evidence of phosphorylation (Figure 6a ). In MAHB-expressing NMuMG cells, these two lower molecular weight bands Figure 5 MAHB-expressing acini become sensitive to TRAIL and TNFa. Sensitivity of MAHB-and ITAMmutant-expressing NmuMG acini to apoptotic-inducing agents. Acini were treated in 3D cultures on day 8 for 20 h with either 1 mg/ml TRAIL or 100 nM TNFa. Cultures were then stained for activated caspase-3 to assess apoptosis induction. Representative images of the same magnification are shown with nuclear staining (DAPI) in blue and activated caspase-3 in red, all structures are GFP þ (not depicted). (1 mg/ml), the Syk kinase inhibitor Piceatannol (1 mg/ml), or a specific Syk inhibitor (0.25 mM) (Lai et al., 2003) . Representative bright field images taken on day 6 are shown, structures are GFP þ (not depicted). Bar, 50 mm. The average score of acinar structures was calculated by scoring 50 acini for each treatment, and it is depicted under the corresponding image. ***Po0.0001 as determined by one-way ANOVA analysis.
were also detectable at low levels in addition to a consistent band that migrated about 28 kDa (Figure 6a ). This higher molecular weight band was constitutively tyrosine-phosphorylated in MAHB-expressing cells (Figure 6a) .
Typical of the transient nature of activated Syk's association with phosphorylated ITAMs in lymphocytes (Keshvara et al., 1997) , inhibition of tyrosine phosphatases is necessary to stabilize the phosphorylated state so that Syk-ITAM interactions can be detected. Pervanadate treatment was previously shown to block PTPmediated ITAM dephosphorylation and stabilize Syk association with Env-associated ITAM in NMuMG cells (Katz et al., 2005) . Under such conditions, we found a direct association of MAHB, but not ITAMmutant, with phosphorylated (activated) Syk (Figure 6b) .
The phosphorylation of ITAMs and Syk association implies a role for Src and Syk activity in the MAHBinduced transformation of MECs in 3D culture. This dependence was established using selective inhibitors of these tyrosine kinases. Pharmacological inhibition of either Src or Syk prevented the depolarization of acinar structures observed as a consequence of MAHB expression (Figure 6c ). Treatment with each of the inhibitors tested resulted in normal polarized structures that resembled those of nontransformed NMuMG cells (Figure 6c ). In agreement with the observed phenotypes, the average score for a population of MAHB-expressing acini receiving each of the treatments was significantly lower than those treated with the vehicle alone (Figure 6c ), returning to the baseline score of acini formed by cells expressing MIGR alone (Figure 2 ). These results indicate that both Src and Syk inhibitors are effective in blocking MAHB-mediated morphological changes associated with transformation. Together with Syk:ITAM binding, these data implicate Src-and Syk-dependent pathways in triggering the depolarization of the acinar structures.
Expression of a nonviral ITAM-containing protein in fibroblasts results in transformation
The ability of MAHB to transform MECs led us to question whether its transformation-inducing properties could be extended to other nonhematopoietic tissue types. Therefore, we examined the consequence of MAHB expression in murine 3T3 fibroblasts. Following the generation of stable pools expressing MIGR, MAHB, and the ITAMmutant, soft agar colony formation and focus formation assays were used to monitor transformation.
To examine the anchorage dependence of these adherent NIH3T3 fibroblasts, cell lines expressing each protein were placed in a colony formation assay. NIH3T3 cells expressing GFP alone (MIGR) formed small colonies after 3 weeks (average size 9077 mm, Figure 7a and b). This behavior was similar to that observed in wild-type NIH3T3 cells (data not shown). Expression of MAHB led to the formation of almost twice as many colonies (data not shown) that were on average significantly (Po0.0001) larger than those expressing either the empty vector or ITAMmutant, indicating a loss of anchorage dependence (13176 mm, Figure 7a and b). Fibroblasts expressing the ITAMmutant variant formed only small colonies (8873 mm, Figure 7a and b), indicating the importance of these motifs in conferring the ability to form colonies.
Another characteristic of transformed NIH3T3 fibroblasts is a loss of contact inhibition, which can be measured by focus formation. NIH3T3 cells expressing MAHB were capable of forming significantly more foci (approximately threefold, Po0.05) than those expressing the empty vector or ITAMmutant (Figure 7c ). The foci formed by MAHB-expressing fibroblasts are also larger, with an average size of 0.715 mm, compared to 0.285 mm of MIGR-and 0.290 mm of ITAMmutantexpressing fibroblasts. These results also confirm the role of the ITAM in the loss of contact inhibition. Collectively, the loss of both contact inhibition and anchorage dependence seen in cells expressing MAHB demonstrate the ability of a nonviral ITAM-containing protein to transform murine fibroblasts. 
Discussion
Most hematopoietic cells, especially those of the immune system, express receptor complexes with ITAM-containing proteins. Lymphocytes, mast cells, macrophages, and NK cells all rely on these tyrosineembedded motifs for a variety of functions, including the generation of signals responsible for survival and activation. Mechanisms exist within hematopoietic cells to regulate ITAM-based signaling. In particular, the expression and spatial positioning of negative coreceptor proteins and cytoplasmic PTPs serve to regulate the duration and strength of signals transduced through ITAM-containing complexes (reviewed in Veillette et al., 2002) . Further regulation can come from the compartmentalization of receptors and signaling proteins within distinct plasma membrane domains (reviewed in Harder and Engelhardt, 2004) . With the discovery of ITAMcontaining proteins expressed outside the hematopoietic system, it has become necessary to look beyond the traditional functions of ITAM-based signaling. In this study, we describe a novel ability of ITAM-containing proteins to promote transformation of nonhematopoietic cells.
Previous work with viral ITAMs (EBV LMP2A, KSHV K1, and MMTV Env) indicated that expression of these proteins in nonhematopoietic cells results in transformation (Lee et al., 1998b; Scholle et al., 2000; Morrison et al., 2003; Katz et al., 2005) . The direct role of this motif in transformation by LMP2A or K1 has not been examined. However, specific mutation of the ITAM tyrosines in MMTV Env was shown to abolish transformation in MECs (Katz et al., 2005) . Whether transformation of nonhematopoietic cells is solely dependent on the ITAMs or cooperates with other sequences associated with these viral proteins has not been determined. We demonstrate here that the ITAMcontaining protein MAHB can transform murine MECs, resulting in disrupted 3D acinar structures and other hallmarks of mammary cell transformation, including colony formation in soft agar, TRAIL and TNFa sensitivity, a loss of E-cadherin, and induction of vimentin expression (Figures 2-5) . These results indicate that the expression of an ITAM-containing protein is sufficient for transformation in this context and does not require a viral protein association for these effects. Importantly, the ability of MAHB to transform these nonhematopoietic cell types was ITAM dependent, as mutation of the critical ITAM tyrosines abolished the transformed phenotype in all assays described in this study.
Both MMTV and EBV cause epithelial cell cancers in vivo and transformation induced by EBV LMP2A and MMTV Env has been studied in epithelial cells in vitro (Scholle et al., 2000; Morrison et al., 2003; Katz et al., 2005) . Therefore, it was unclear whether ITAMdependent transformation was limited to this cell type. Thus, we wanted to determine the consequence of expression in another nonhematopoietic cell type, and chose NIH3T3 fibroblasts, as this is the most common model used to examine cell transformation. Indeed, expression of MAHB in murine fibroblasts resulted in ITAM-dependent transformation, as indicated by the loss of both anchorage dependence and contact inhibition, key properties of adherent cells (Figure 7 ). Therefore, our results suggest a previously unappreciated action of cellular ITAM-containing proteins, to promote transformation when expressed in various cell types outside the hematopoietic system.
The ability of ITAM-containing proteins to transform nonhematopoietic cells raises the question of how ITAM signaling occurs in these cells. While ITAMbased signal transduction has been well characterized in hematopoietic cells, the specific molecules involved and pathways activated in nonhematopoietic cells are less clear. Both MMTV Env and MAHB appear to be dependent upon Src and Syk family tyrosine kinases for their transforming effect (Figure 6 and (Katz et al., 2005) ). This dependence suggests that signaling is occurring by a mechanism similar to lymphocyte activation (Niiro and Clark, 2002) . However, the viral ITAM-containing protein LMP2A appears to be phosphorylated by Csk, not Src-family tyrosine kinases, in epithelial cells (Scholle et al., 1999) . Therefore, the specific tyrosine kinases involved in the initiation of ITAM-based signaling in nonhematopoietic cells may not be well conserved and warrants further investigation.
It has been demonstrated that LMP2A activates the PI3K/Akt pathway in epithelial cells (Scholle et al., 2000) . This pathway is also activated by ITAM signaling in hematopoietic cells, where it functions to promote proliferation and survival (Niiro and Clark, 2002) . The ability of LMP2A to activate this pathway suggests that it may be common in ITAM-based signaling. Thus, enhanced proliferative and survival signals produced by ITAM-containing proteins in nonhematopoietic cells could contribute to their transformation. Another mechanism by which LMP2A may stimulate proliferation and therefore transformation is through activation of b-catenin signaling (Morrison et al., 2003; Morrison and Raab-Traub, 2005) . However, our knowledge of the signal transduction events leading to ITAM-dependent transformation in nonhematopoietic cells is still being characterized.
Another important question centers on why an ITAM-based signal is transforming when it occurs outside of the hematopoietic system. A number of tyrosine kinase-based signaling proteins, including growth factors, integrins, cadherins, and cytokine receptors, exist in nonhematopoietic cells. As an ITAM-containing protein will compete with these receptors for SH2-containing adaptor and effector molecules, alteration in the equilibrium of bound effector molecules could lead to cell transformation. Evidence for this type of competition comes from the EGF receptor, shown to promote cell migration by competing Shc away from integrin b4 (Mainiero et al., 1996) . Additionally, crosstalk between these receptors could also exist, causing imbalanced signaling cascades that result in transformation. Instead of competition for signaling effectors, phosphorylation of ITAM-containing proteins could lead to the activation of tyrosine-based signals that could cooperate to transform nonhematopoietic cells. A strong positive signal generated by ITAM-containing proteins resulting in transformation has been suggested for LMP2A (Portis and Longnecker, 2004) .
A nonmutually exclusive explanation for the transforming ability of ITAM-containing proteins involves inappropriate regulation of ITAM-dependent signal transduction, such as aberrant expression of ITAMcontaining proteins in an environment lacking ITIMcontaining proteins or other negative regulators. The ability of ITAM-containing complexes to signal tonically in the absence of ligand interactions is fairly well established for lymphocytes (Monroe, 2006) . However in this context, balancing the activation and spatial positioning of protein tyrosine kinases and phosphatases in proximity to ITAM-containing complexes allows for precise tuning of tonic signals. This balance is necessary in order to prevent constitutively hyperactive receptor signaling and proliferation disorders. The negative regulatory coreceptors responsible for mediating this balance in hematopoietic cell-expressed ITAM complexes are generally lacking in epithelial and fibroblast cells (Staub et al., 2004) . Therefore, nonhematopoietic cells expressing ITAM-containing proteins could be predicted to display phenotypes consistent with those seen upon unregulated tonic signaling in lymphocytes.
A precise role for ITAM-dependent signaling in nonhematopoietic cell transformation must be considered in the context of the multiple disruptions, or 'hits', thought to be necessary for tumor formation or invasiveness. In the case of MMTV, a retrovirus, the ITAM-containing protein Env is expressed in nonhematopoietic cells as a consequence of viral infection. We speculate that ITAM-dependent signaling could cooperate with proviral integration next to cellular protooncogenes to provide additional 'hits' required for solid tumor formation. For example, tumorigenesis could be driven by ITAM signaling by Env and insertion of the proviral genome near Wnt or FGF family genes (Callahan and Smith, 2000) . Similarly, the EBV LPM2A protein signals through other motifs in addition to the ITAM (Ikeda et al., 2000 (Ikeda et al., , 2001 Morrison and RaabTraub, 2005) , and EBV encodes additional proteins such as LMP1 that contribute to transformation (ThorleyLawson, 2001 ). Cellular ITAM-containing proteins may also preferentially collaborate with other disturbances in the induction of tumorigenesis, a possibility currently under investigation.
The data presented here implicate ITAM-containing proteins as bona fide oncoproteins in the transformation of murine mammary epithelial cells and fibroblasts. The ability of this signaling motif to have such an effect is notable, as most proteins with strong transforming ability possess either enzymatic or transcriptional activity. Thus, the transformation-inducing properties of an ITAM lie in its ability to recruit, organize, and promote activation of normal cellular signal-transducing proteins. Identification of the specific downstream effectors operating in ITAM signaling in nonhematopoietic cells will lead to a better understanding of ITAM-induced transformation. In addition, the findings of this study suggest that viral ITAMcontaining proteins may play a more prominent role in transformation initiated by these viruses than previously appreciated.
Materials and methods

Cell lines and retroviral infection
NMuMG and NIH3T3 cell lines were obtained from the American Type Culture Collection. All NMuMG lines were maintained in DMEM containing 10% heat-inactivated FBS, 2 mM L-glutamine, 100 U/ml penicillin-streptomycin, and 10 mg/ml insulin at 371C and 10% CO 2 . All NIH3T3 lines were maintained in DMEM containing 10% heat-inactivated FBS, 2 mM L-glutamine, 100 U/ml penicillin-streptomycin, and 50 mM 2-ME at 371C and 10% CO 2 .
The construction of MAHB and its ITAMmutant variant and cloning into the MIGR1 retroviral vector has been previously described (Bannish et al., 2001) . Briefly, the fusion protein constructs were transfected with CaPO 4 into the Bosc23 packaging cell line. To generate stable lines expressing each construct, 0.25 Â 10 6 NMuMG cells or 0.5 Â 10 6 NIH3T3 cells were infected by centrifugation at 200 g for 1.5 h at 251C in 4 ml of 1:1 growth medium to retroviral supernatant containing polybrene (4 mg/ml). After infection, cells were grown in medium and sorted 48 h post-transduction to obtain pure GFP-expressing populations.
Flow cytometry and immunofluorescence
Analysis of GFP expression (as an indicator of successful retroviral infection and protein expression) was performed by flow cytometry on a FACSCalibur (BD Biosciences). Wildtype NMuMG cells were used as a negative control. To determine E-cadherin expression by flow cytometry, 2D cultures of 10 6 NMuMG cells were used. Rat anti-human E-cadherin (Sigma-Aldrich) was used with goat anti-rat IgG-AlexaFluor-647 (Molecular Probes), where normal rat IgG served as the negative control.
To directly determine expression of MAHB and ITAMmutant, 2D cultures of NMuMGs in 16-well slides were used. Cell staining was performed using the BD Cytofix/Cytoperm kit (BD Biosciences) with a rat monoclonal anti-HA high affinity antibody (clone 3F10, Roche) followed by goat anti-rat IgG-Alexa Fluor-555 antibody (Molecular Probes). Images were captured and analysed using a Â 40 objective on a Zeiss Axiovert 200 M inverted epifluorescence microscope equipped with PCO SensiCam QE high-resolution camera and Slidebook image analysis software (Intelligent Imaging Innovations).
3D cultures
NMuMG cells (1 Â 10 4 cells per chamber) were cultured on recombinant basement membrane (Matrigel, BD Biosciences) cushions according to the published protocol, without exogenous EGF (Debnath et al., 2003) . The structures were analysed using the microscope and software as described above. For each independent experiment, 50-200 structures were scored based on the parameters described in the Results section. For inhibitor studies, PP2, Piceatannol, and Syk Inhibitor 31 (Lai et al., 2003) (all from EMD) were added on day 3 of culture and scored and imaged as described above on day 6. For apoptosis assays, TNFa (R&D Systems) or TRAIL (BIOMOL Research Laboratories, Inc.) was added on day 8 of culture for 20 h and then stained for cleaved caspase-3. Cell staining was performed as described (Debnath et al., 2003) with rabbit anticleaved caspase-3 (Cell Signaling), rabbit anti-E-cadherin (Sigma-Aldrich), rabbit anti-Vimentin (H-84, Santa Cruz Biotechnology), and anti-rabbit IgG-AlexaFluor-647 (Molecular Probes).
Colony formation assays
To assay for anchorage-independent growth, NMuMG cells (2 Â 10 4 ) were suspended in DMEM:F-12 (1:1) medium containing 20% horse serum and 0.8% methocellulose (Sigma-Aldrich). Cells from each NMuMG line were plated in six-well plates precoated with 0.6% agar base in DMEM. Cells were fed with fresh medium every 5 days. Colonies were counted and measured using a graduated reticule under microscope at Â 10 magnification on day 28.
NIH3T3 cells (1 Â 10 4 ) were suspended in 0.3% agar in DMEM containing 10% FBS. Cells from each transduction group were plated in six-well plates precoated with 0.6% agar base in DMEM containing 10% FBS. Cells were fed with fresh top agar (0.3% agar in DMEM with 10% FBS) every 5 days. Colonies were counted and measured as with NMuMGs on day 21.
Focus formation assays
To assay for contact inhibition, NIH3T3 cells (4 Â 10 6 ) were seeded in a 10 cm dish for 1 week after reaching confluence. Foci were stained with 0.005% crystal violet, and the number of foci in a 4 cm 2 area were counted and measured.
Western blotting and immunoprecipitation
In order to examine the phosphorylation status of MAHB and ITAMmutant, 3 Â 10 6 NMuMG cells were washed in media without serum and then lysed in lysis buffer (1% NP-40, 50 mM Tris pH 7.4, 150 mM NaCl, 5 mM EGTA, 0.5% w/v sodium deoxycholate, 1 mM sodium orthovanadate, protease inhibitor cocktail (Roche), 1 mM phenylmethylsulfonyl fluoride, 0.5% w/v sodium azide) for 15 min on ice. Equivalent amounts of protein were separated by SDS-PAGE and transferred to PVDF. Immunoblots were probed with antipTyr (4G10, Upstate), developed with ECL. Location of MAHB and ITAMmutant was determined by stripping the blots in strip buffer (2% SDS, 62.5 mM Tris, 0.7% b-mercaptoethanol) for 30 min shaking at 621C and detecting the anti-HA.11 (Covance) probe using ECF.
To look for association of phosphoproteins with either chimeric protein, 2D cultures of (15 Â 10 6 ) NMuMG cells were treated with 50 mM sodium pervanadate as previously described (Bannish et al., 2001 ) and harvested using cell lifters. Cells were lysed in Phosphosafe buffer (EMD) supplemented with protease inhibitor cocktail (Roche), 1 mM phenylmethylsulfonyl fluoride, and 0.5% w/v sodium azide for 15 min at room temperature. Equal amounts of protein were precleared with Protein G and subsequently incubated with mouse IgG or a mouse monoclonal HA antibody (Covance) overnight. Precipitates were then collected, washed, separated by SDS-PAGE and transferred to PVDF membranes. Immunoblots were probed with anti-pTyr (4G10, Upstate), anti-HA.11 (Covance), and anti-Syk (N-19, Santa Cruz Biotechnology), and detected by ECL or ECF, being stripped as above in between.
